Health and Healthcare
Health and Healthcare Articles
Pfizer and BioNTech S.E. aim to begin delivering 300 million doses of their vaccine for COVID-19 in 2021, but in the meantime, these companies will get a nice payoff.
Published:
The current focus on controlling the COVID-19 pandemic, companies that provide other health care products and services have received less attention from investors and analysts. Here are seven that...
Published:
There are no assurances that this stock will keep rising after such a rapid rise, but many investors with a long-term view now likely will view any pullbacks as opportunities to buy the stock.
Published:
BioNTech is one of the leading companies in the race to a COVID-19 vaccine. With its shares up more than 160% year to date, it’s time to capitalize.
Published:
Lexicon Pharmaceuticals shares surged on Tuesday after the company announced positive topline data for its late-stage studies in type 2 diabetes.
Published:
Moleculin Biotech joins the ever-expanding list of coronavirus stocks as the company announced that a second round of independent laboratory testing has confirmed the antiviral activity of WP1122.
Published:
Immuron continued its winning streak on Tuesday after the company announced that its IMM-124E has demonstrated neutralizing activity against the severe acute respiratory syndrome due to the virus...
Published:
While the United States considers its COVID-19 spread with horror, two much smaller nations have suffered tremendously as well.
Published:
Sorrento Therapeutics has announced that its treatment for COVID-19 had cleared its Phase 2 study in hospitalized patients with moderate to severe coronavirus infections.
Published:
GlaxoSmithKline has announced that it is acquiring a 10% stake in the German biopharma firm CureVac.
Published:
BioNTech and Pfizer are leading the pack of COVID-19 vaccine stocks as this collaboration came out with more positive news regarding their ongoing German Phase 1/2 study.
Published:
As the COVID-19 pandemic continues around the world, and the number of cases in the United States rises relentlessly, there are now three countries that have over a million confirmed cases.
Published:
These four sizzling biotech stocks trading under the $10 level have big upside to the analysts' price targets. All of them are rated Buy at Goldman Sachs.
Published:
PhaseBio Pharmaceuticals announced early on Friday that it has initiated its midstage study evaluating a treatment for the novel coronavirus.
Published:
The number of COVID-19 cases continues to rise, which will only create more demand for coronavirus stocks. 24/7 Wall Street has picked out a few of the best and brightest that could still see a big...
Published:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.